As of 2024-12-12, the Fair Value of Biovaxys Technology Corp (BIOV.CN) is -0.10 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.06 CAD, the upside of Biovaxys Technology Corp is -258.75%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-10-31 | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 5Y Avg | |
| Net income | -0.23 | -1.17 | -6.46 | -11.73 | -7.69 | -5.46 |
| YoY growth | -42.73% | -410.30% | -449.93% | -81.60% | 34.45% | -190.02% |
| Market Cap (mil) | 15.36 |
| P/E | |
| Forward P/E |
| EPS | -0.02 |
| Avg earnings growth rate | -190.02% |
| TTM earnings | -4.88 |